Lumigan (Bimatoprost) for glaucoma & growth of eyelashes

Lumigan (Bimatoprost) is a synthetic analog of prostaglandin that increases the outflow of aqueous humor resulting in a reduction in the intraocular pressure. It is used to treat the following conditions:

  • For the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension (Lumigan, Vistitan).

  • Treatment for the growth of eyelashes (Latisse).

Lumigan (Bimatoprost) Dose in Adults

Lumigan use in the treatment of  Elevated intraocular pressure:

  • Instill one drop into the affected eye once a day in the evening.
  • With concomitant administration of other ophthalmic solutions, separate administration by at least five minutes.
  • More than once a day administration is not recommended.

Use in the treatment for the growth of eyelashes (Latisse):

  • For Topical Ophthalmic use:
  • Place one drop on the applicator and apply evenly along the skin of the upper eyelid at the base of eyelashes once a day at bedtime
  • Use a clean applicator for the second eye.

Lumigan (Bimatoprost) Dose in Childrens

Use in the treatment of raised intraocular pressure (Lumigan):

  • Adolescents older than 16 years:
    • Refer to adult dosing.

Use in the treatment for the growth eyelashes (Latisse):

  • Children older than 5 years and Adolescents:
    • Refer to adult dosing.

Pregnancy Risk Factor: C

  • Pregnancy has not been associated with adverse maternal and fetal effects.
  • The lowest dose is best when used with punctual occlusion.

Bimatoprost use during breastfeeding:

  • It is unknown if bimatoprost can be absorbed into breastmilk.
  • The manufacturer weighs the benefits for the mother and the risks for the fetus.

Lumigan (Bimatoprost) Dose in Renal Disease:

  • Dose adjustment in patients with kidney disease is not recommended by the manufacturer.

Lumigan (Bimatoprost) Dose in Liver Disease:

  •  Dose adjustment in patients with liver disease is not recommended by the manufacturer. 

Common Side Effects of Lumigan (Bimatoprost) Include:

  • Dermatologic:
    • Increased growth in the number of eyelashes
  • Ophthalmic:
    • Conjunctival hyperemia
    • Eye pruritus

Less Common Side Effects of Bimatoprost Include:

  • Central nervous system:
    • Headache
    • Foreign body sensation of eye
  • Dermatologic:
    • Erythema of eyelid
    • Hyperpigmentation of eyelashes
    • Local skin hyperpigmentation
  • Endocrine & metabolic:
    • Hirsutism
  • Hepatic:
    • Abnormal hepatic function tests
  • Infection:
    • Infection
  • Neuromuscular & skeletal:
    • Asthenia
  • Ophthalmic:
    • Dry eye syndrome
    • Eye Irritation
    • Allergic Conjunctivitis
    • Asthenopia
    • Blepharitis
    • Burning Sensation of Eyes
    • Cataract
    • Conjunctival Edema
    • Conjunctival Hemorrhage
    • Eye Discharge
    • Eye Pain
    • Iris Hyperpigmentation
    • Lacrimation
    • Photophobia
    • Superficial Punctate Keratitis
    • Visual Disturbance

Contraindication to Bimatoprost Include:

  • Allergy reactions to bimatoprost and any component of this formulation

Warnings and Precautions

  • Bacterial Keratitis
    • Inadvertent contamination may lead to bacterial keratitis.
  • Ocular effects
    • Permanent brownish pigmentation may occur in the iris, eyelid skin, periorbital tissues, and eyelashes.
  • Ocular inflammation:
    • Patients with active intraocular inflammation or uveitis should be cautious as this may worsen the condition.
  • Ocular disease:
    • The use of it in patients with angle-closure, Neovascular Glaucoma, and Inflammatory Glaucoma has not yet been investigated.
    • Avoid aphakic patients and pseudophakics with a damaged posterior lens capsule.

Bimatoprost: Drug Interaction

Risk Factor C (Monitor therapy)

Latanoprost

The concomitant use of Latanoprost and Bimatoprost may result in increased intraocular pressure.

LatanoprosteneBunod

The concomitant use of Bimatoprost and LatanoprosteneBunod may result in increased intraocular pressure.

Nonsteroidal Anti-Inflammatory Agents

May diminish the therapeutic effect of Prostaglandins (Ophthalmic). Nonsteroidal Anti-Inflammatory Agents may also enhance the therapeutic effects of Prostaglandins (Ophthalmic).

Nonsteroidal Anti-Inflammatory Agents (Ophthalmic)

May diminish the therapeutic effect of Prostaglandins (Ophthalmic). Nonsteroidal Anti-Inflammatory Agents (Ophthalmic) may enhance the therapeutic effect of Prostaglandins (Ophthalmic).

How to administer Bimatoprost?

  • Latisse:

    • Before application, clean face, remove make-up and contact lenses.
    • Apply the medicine with the sterile applicator provided and blot any excess solution with a tissue.
    • Do not apply to the lower eyelash line.
    • The applicators should not be reused. A new applicator should b used for the other eye.
    • More than once application is not recommended and will not result in the rapid growth of the eyelashes.
    • Contact lenses may be inserted after 15 minutes of administering the drug.
  • Lumigan, Vistitan

    • It may be used with other medicines that lower the intraocular pressure.
    • Contact lenses should be reinserted after 15 minutes of administering the drug.
    • With concomitant administration of other ophthalmic solutions, it should be separated by an interval of 5 minutes.

Mechanism of action of Lumigan (Bimatoprost):

  • It is a synthetic analog to prostaglandin. It increases the flow of aqueous humor, causing a decrease in intraocular pressure.
  • This causes the growth of eyelashes, increasing the percentage and duration of hair growth.

It has beenThe beginning of actionapproximately 4 hours.

 peak effectIt can be seen within 8 to 12 hours. 88% of the drug can be absorbed. protein-bound. It isMetabolizedAfter reaching the systemic circulation, the process of oxidation or glucuronidation takes place.

The intravenous administration of the medication is completed.half-life eliminationIt takes approximately 45 minutes to achieve peak effects.

The peak effect can be seen in around 10 minutes. It isexcretedPrimarily in the urine

International Brands of Lumigan (Bimatoprost):

  • Latisse
  • Lumigan
  • Lumigan RC
  • Vistitan
  • Bimagan
  • Bimaprost
  • Bimast
  • Bimat
  • Bimato-Vision
  • Bimatoswix
  • Bimican
  • Careprost
  • Glamigan
  • Glash Vista
  • Lumiprox
  • Matrocond
  • Sturiban
  • Vizibim

Bimatoprost brands in Pakistan:

Bimatoprost [Eye Drops 2 mg/5ml]

Brimogan Helix Pharma (Private) Limited
Timodine Hygeia Pharmaceuticals

Bimatoprost [Eye Drops 0.03 %w/v]

Lumigan Barrett Hodgson Pakistan (Pvt) Ltd.

Comments

NO Comments Found